MedPath

The effect ofTranscutaneous electrical nerve stimulation onrestless legs syndrome

Not Applicable
Recruiting
Conditions
Severity of restless leg syndrome in hemodialysis patients.
Chronic kidney disease, stage 5
N18.5
Registration Number
IRCT20220601055047N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Hemodialysis patients aged 18-75 years and older
suffering from restless leg syndrome based on the self-report of the hemodialysis patient
no history of neurological and mental illness except restless leg syndrome
Absence of vascular diseases except restless leg syndrome
absence of neuromuscular disorders, absence of crisis
experience during the last 3 months

Exclusion Criteria

The patient's unwillingness to cooperate
Antispasmodic use in the past two weeks
Anticonvulsant use within the past two weeks
Use of sedatives in the past two weeks
Use of antidepressants in the past two weeks
Use of herbal medicines during the last two weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of restless legs syndrome. Timepoint: 3 shifts of 20 minutes. Method of measurement: Restless Leg Syndrome International Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath